CPAP Reduces Cardiovascular Events
Worsening severity of untreated sleep apnea is associated with a greater risk of cardiovascular
events compared to BMI adjusted controls and those with OSA on treatment as demonstrated in a 2005 landmark cohort study by Marin, Lancet . As Figure A demonstrates, OSA patients undergoing CPAP therapy were far less likely to experience a cardiac event compared to individuals diagnosed with OSA who did not follow CPAP therapy protocol; 9% of treated patients vs. 30% of untreated.
Measurably Better Outcomes – Even for Patients Who Have Previously Tried & Failed to Wear CPAP
In an objectively measured study, our patients demonstrated treatment compliance of over 87% (national average is 62%). Figure B compares the compliance data after 90 days of treatment from Encore of over 2,000 consecutive BCBS patients treated with CPAP dispensed by Sleep Centers of Middle Tennessee to the complete national database of 6.8 million patients treated by DME companies.
With combined diagnostic and treatment protocols, our state of the art sleep labs are able to provide the most economic option for an in-lab sleep study in the region (1/3 the cost of hospitals) while delivering the highest standard of care (Figure C). Even the cost of CPAP is less at Sleep Centers of Middle Tennessee. Patients with Blue Cross Blue Shield are now eligible to save even more.